GMO Product Platform, Inc.
GMO Product Platform, Inc. Fundamental Analysis
GMO Product Platform, Inc. (3695.T) shows weak financial fundamentals with a PE ratio of 47.43, profit margin of 2.28%, and ROE of 7.05%. The company generates $7.2B in annual revenue with weak year-over-year growth of -1.79%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 30.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 3695.T's fundamental strength across five key dimensions:
Efficiency Score
Weak3695.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate3695.T shows balanced valuation metrics.
Growth Score
Weak3695.T faces weak or negative growth trends.
Financial Health Score
Excellent3695.T maintains a strong and stable balance sheet.
Profitability Score
Weak3695.T struggles to sustain strong margins.
Key Financial Metrics
Is 3695.T Expensive or Cheap?
P/E Ratio
3695.T trades at 47.43 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 3695.T's PEG of -0.55 indicates potential undervaluation.
Price to Book
The market values GMO Product Platform, Inc. at 3.03 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 18.52 times EBITDA. This signals the market has high growth expectations.
How Well Does 3695.T Make Money?
Net Profit Margin
For every $100 in sales, GMO Product Platform, Inc. keeps $2.28 as profit after all expenses.
Operating Margin
Core operations generate 5.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.05 in profit for every $100 of shareholder equity.
ROA
GMO Product Platform, Inc. generates $1.65 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
GMO Product Platform, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
GMO Product Platform, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
3695.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
47.43
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.55
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.03
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.15
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.27
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.18
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.07
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How 3695.T Stacks Against Its Sector Peers
| Metric | 3695.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 47.43 | 25.83 | Worse (Expensive) |
| ROE | 7.05% | 1278.00% | Weak |
| Net Margin | 2.28% | -43774.00% (disorted) | Weak |
| Debt/Equity | 0.27 | 0.80 | Strong (Low Leverage) |
| Current Ratio | 1.18 | 10.63 | Neutral |
| ROA | 1.65% | -1539613.00% (disorted) | Weak |
3695.T outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews GMO Product Platform, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
52.93%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
33.54%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
61.80%
Industry Style: Cyclical, Value, Infrastructure
High Growth